VALYSTR · Stock research
Listed on NasdaqCM. What the market is pricing into Rallybio Corporation (RLYB) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceutical Preparations · market value about $84.2M · P/E 3.4 · revenue $434,000 (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows